Andrew Carlick

CEO of DBD


With almost 30 years experience in the nuclear industry, Andrew’s career stems from a Chemical Engineering background with extensive experience in his early career in commissioning of nuclear plants.   

Andrew established DBD in 2004 and he has developed and led them so they now operate successfully in the UK, France, Japan, the Middle East and US, mainly in the nuclear fission and fusion markets. Andrew is a keen supporter of R&D and has supported DBD in developing engineering solutions to key issues in the nuclear market.

Andrew is a Fellow of the Institute of Chemical Engineers.